FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/27/2020 

3. Issuer Name and Ticker or Trading Symbol

PLURISTEM THERAPEUTICS INC [PSTI]
(Last)        (First)        (Middle)

24 BODENHIMER STREET
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

TEL AVIV, L3 6200838      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 2511311 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Warrant 4/8/2019 4/8/2024 Common Stock 47143 (1)$7 (1)D  

Explanation of Responses:
(1) Reflects the 1-for-10 reverse stock split effected by Pluristem Therapeutics Inc. on July 25, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP
24 BODENHIMER STREET
TEL AVIV, L3 6200838

X


Signatures
Clover Wolf Capital - Limited Partnership By: Clover Wolf Ltd., its General Partner /s/ Adi Wolf, Chief Executive Officer and Managing Member6/29/2020
**Signature of Reporting PersonDate

Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Jun 2020 to Jul 2020 Click Here for more Pluristem Therapeutics Charts.
Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Jul 2019 to Jul 2020 Click Here for more Pluristem Therapeutics Charts.